Twenty-nine Cornell MBA students in the Samuel Curtis Johnson Graduate School of Management, together with PhD candidates from across Cornell University and postdoctoral fellows from the Memorial Sloan Kettering Cancer Center, have joined the third cohort of Cornell’s Life Sciences Technology Innovation Fellows program, an interdisciplinary entrepreneurship and translation program offered by the Cornell SC Johnson College of Business.
After its inaugural cycle in 2022-23, Cornell University’s Life Sciences Technology Innovation Fellowship, formerly known as the BioEntrepreneurship Initiative, enters its second year with a new cohort of 15 business students and 12 researchers who are eager to embark on their journeys to becoming C-suite startup leaders.
Mike Misch, MBA ’23, a member of the inaugural Life Sciences Technology Innovation Fellowship (LSTIF) cohort, formerly known as the Cornell…
As biotechnology and pharmaceutical professionals continue efforts to make advances in medicinal drug formulation, safety and efficacy, experts in the field…
A small biotech, armed with technology out of Cornell University and a former Dana-Farber chief at its helm, has raised $90 million for its cancer drugs.
Members of the Cornell entrepreneurial community gathered to celebrate a successful first year of the Read More
It’s time for the real world: Three brand new robust companies – one turning carbon dioxide into jet fuel, another enabling a green hydrogen economy and a…